Lund-Hansen Torben

Insider profile

Performance

Overall performance
3.2

Performance over holding periods
3.2
30 days 90 days 120 days
Average return 16% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
1 0% Buy
34 71% Buy
47 69% Buy
Lund-Hansen Torben's trades of Y-mAbs Therapeutics, Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2024-08-30 2024-08-28 S Sale
78,237 +45.1%
192.62
US$2,647,266
78,237 +45.1% 192.62 US$2,647,266
2024-08-28 2024-08-28 PrS Proposed sale
42,671
362.55
US$1,555,458
42,671 362.55 US$1,555,458